CLEARPOINT NEURO INC's ticker is CLPT and the CUSIP is 18507C103. A total of 56 filers reported holding CLEARPOINT NEURO INC in Q3 2022. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,834,813 | -31.3% | 1,364,234 | -0.7% | 0.00% | – |
| Q2 2023 | $9,946,138 | +186.8% | 1,373,776 | +234.3% | 0.00% | – |
| Q1 2023 | $3,467,861 | -0.8% | 410,884 | -0.5% | 0.00% | – |
| Q4 2022 | $3,495,925 | -18.3% | 412,742 | -0.0% | 0.00% | – |
| Q3 2022 | $4,277,000 | +10.1% | 412,820 | +38.7% | 0.00% | – |
| Q2 2022 | $3,884,000 | -68.1% | 297,693 | -74.6% | 0.00% | – |
| Q1 2022 | $12,178,000 | -7.7% | 1,169,853 | -0.6% | 0.00% | – |
| Q4 2021 | $13,198,000 | -36.1% | 1,176,355 | +1.1% | 0.00% | -100.0% |
| Q3 2021 | $20,652,000 | -5.9% | 1,163,572 | +1.2% | 0.00% | 0.0% |
| Q2 2021 | $21,940,000 | +224.2% | 1,149,210 | +259.0% | 0.00% | – |
| Q1 2021 | $6,767,000 | +786.9% | 320,087 | +565.9% | 0.00% | – |
| Q4 2020 | $763,000 | +182.6% | 48,065 | -2.7% | 0.00% | – |
| Q3 2020 | $270,000 | +52.5% | 49,400 | -0.9% | 0.00% | – |
| Q2 2020 | $177,000 | +490.0% | 49,872 | +497.8% | 0.00% | – |
| Q1 2020 | $30,000 | – | 8,343 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parian Global Management LP | 678,999 | $12,962,000 | 5.56% |
| Taylor Frigon Capital Management LLC | 175,690 | $3,354,000 | 1.05% |
| Mayo Clinic | 38,114 | $728,000 | 0.80% |
| APIS CAPITAL ADVISORS, LLC | 40,000 | $764,000 | 0.66% |
| Blackcrane Capital, LLC | 27,653 | $528,000 | 0.64% |
| Parian Global Management LP | 75,000 | $1,432,000 | 0.62% |
| Triumph Capital Management | 29,509 | $500,000 | 0.29% |
| AlphaCentric Advisors LLC | 50,000 | $955,000 | 0.26% |
| KIRR MARBACH & CO LLC /IN/ | 45,200 | $863,000 | 0.24% |
| Kepos Capital LP | 125,000 | $2,386,000 | 0.18% |